Figure 3From: Evaluation of etoricoxib in patients undergoing total knee replacement surgery in a double-blind, randomized controlled trial Responder Analyses showing the percent of patients who improved by different percent levels of pain intensity reduction at rest on Days 1 to 3 (Panel A) and Days 4 to 7 (Panel B) and at knee flexion on Days 1 to 3 (Panel C) and Days 4 to 7 (Panel D). Back to article page